Considering the importance of ZEB1 in EMT initiation and chemoresistance, our study indicates that FLASH-mediated ZEB1 regulation could be exploited to design therapies directed toward ZEB1 degradation in cells undergoing EMT to block this key step in cancer progression. This evidence concerns the gene CASP8AP2 and cancer.